Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
627 hedge funds and large institutions have $11.3B invested in Exact Sciences in 2024 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 230 increasing their positions, 204 reducing their positions, and 88 closing their positions.
112% more call options, than puts
Call options by funds: $490M | Put options by funds: $231M
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
13% more repeat investments, than reductions
Existing positions increased: 230 | Existing positions reduced: 204
0.77% more ownership
Funds ownership: 89.82% → 90.59% (+0.77%)
3% less funds holding
Funds holding: 648 → 627 (-21)
6% less capital invested
Capital invested by funds: $12B → $11.3B (-$671M)
17% less first-time investments, than exits
New positions opened: 73 | Existing positions closed: 88
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$352M |
| 2 |
Millennium Management
New York
|
+$172M |
| 3 |
Holocene Advisors
New York
|
+$134M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$91M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$47.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$272M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$175M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$131M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$122M |
| 5 |
Morgan Stanley
New York
|
-$90M |
EXAS Hedge Fund Activity: Q1 2024 in Review
627 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2024, worth a combined $11.3B — down 5.6% from $12B a quarter earlier.
Sellers outnumbered buyers: 88 funds closed out of EXAS and 73 opened new positions — a net loss of 15 holders — while 204 trimmed existing stakes and 230 added.
The largest buyer was Capital World Investors, adding an estimated $352M. The largest seller was JP Morgan Chase, cutting an estimated $272M.
- 627 institutional investors held Exact Sciences (EXAS) as of Q1 2024, down from 648 in Q4 2023.
- Funds reported $11.3B of Exact Sciences stock for Q1 2024, down 5.6% quarter-over-quarter.
- 73 funds opened new Exact Sciences positions in Q1 2024 and 88 closed out, a net change of -15 holders.
- The largest Exact Sciences buyer in Q1 2024 was Capital World Investors, an estimated $352M added.
- The largest Exact Sciences seller in Q1 2024 was JP Morgan Chase, an estimated $272M sold.
Based on aggregated 13F filings for Q1 2024.